膵がんの免疫抑制性微小環境の構築機序を解明~がん関連線維芽細胞と骨髄由来抑制細胞との相互作用~

ad

2026-04-23 国立がん研究センター,ナショナルセンター医療研究連携推進本部

国立がん研究センターの研究グループは、膵がんにおける免疫抑制性微小環境の形成機構を解明した。腫瘍内ではミエロイド系細胞が多いほど予後不良であり、特に骨髄由来抑制細胞(MDSC)が強く関与することを確認。さらに、がん関連線維芽細胞(CAF)が分泌するMIFと、MDSC上のCD74との相互作用により、MDSCの腫瘍内への遊走・分化・活性化が促進され、免疫抑制環境が形成されることを明らかにした。このCAF–MDSCネットワークが免疫療法抵抗性の一因と考えられる。本成果は、これらの相互作用を標的とした新たな免疫療法開発や、免疫抑制環境の解除による治療効果向上につながる可能性を示す。

膵がんの免疫抑制性微小環境の構築機序を解明~がん関連線維芽細胞と骨髄由来抑制細胞との相互作用~

<関連情報>

MIF-CD74経路は膵管腺癌の腫瘍微小環境におけるMDSCの浸潤を促進する MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma

Hironori Fukuda, Kosuke Arai, Eri Hashimoto, Keisuke Sekine, Yasuhito Arai, Nobuyoshi Hiraoka, Aya Hirata, Makiko Yamashita, Kenta Narumi, Ayaka Kikuchi, Eri Sawai, Yuria Sawada, Ayana Sunami, Yukihiro Mizoguchi, Ryoichi Sadahiro, Yukiko Aikawa, Yasuko Henmi, Genki Okumurai, Eri Sugiyama, Mami Takahashi…Kazunori Aoki
Cancer Letters  Available online: 20 February 2026
DOI:https://doi.org/10.1016/j.canlet.2026.218348

Highlights

  • The underlying mechanism of a strong immunosuppressive TME in PDAC remains unclear.
  • MDSCs play a crucial role in creating an immunosuppressive TME.
  • CD74+MDSCs infiltrate PDAC tissues through interaction with MIF produced by CAFs.
  • Inhibition of MIF-CD74 interaction may improve the immunosuppressive condition.

Abstract

Immune checkpoint inhibitors show insufficient efficacy against pancreatic ductal adenocarcinoma (PDAC). The tumor microenvironment (TME) has a remarkable influence on responsiveness to cancer immunotherapy. The aim of this study was to investigate immunosuppressive characteristics of TME in PDAC tissues. The flow cytometry (FCM) of PDAC surgical specimens revealed that the profile of tumor-infiltrating leukocytes was classified into myeloid cell- and T-cell-dominant subtypes; the myeloid subtype was associated with poorer patient outcomes. Myeloid-derived suppressor cells (MDSCs) showed the highest hazard ratio among various myeloid cell types. Single-cell RNA sequencing and FCM revealed that most MDSCs, but not lymphocytes, in PDAC tissues characteristically express CD74. Macrophage migration inhibitory factor (MIF), a CD74 ligand, was highly expressed in cancer-associated fibroblasts (CAFs) and cancer cells. Spatial transcriptomics demonstrated that the MIF-CD74+ myeloid cell interaction was recognized in CAF-dominant areas in PDAC tissue. CAFs expressing immune suppressor molecules such as MFAP5 and LRRC15 were consistent with MIF+ CAFs. Furthermore, MIF+ CAFs enhanced the migratory activity of MDSCs and promoted MDSC induction and activation. In the murine model, MDSCs were significantly increased in MIF-expressing PDAC tumors, as were CD74+ M-MDSCs per M-MDSC, confirming in vivo interaction between CD74 and MIF. MDSCs play a crucial role in creating an immunosuppressive TME in PDAC; the MIF-CD74 axis drives interactions between MDSCs and CAFs.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました